Member Info for hunkymonkey

The link to evrh is simple. Is it going to take off, people of a certain generation believe, you go and experience the event, it's interesting when you read the comments about the event, those that will and those that won't and for what reasons. This marsh mellow event is a new way, clearly the demand is there with the numbers. Perhaps just a case of waiting for it to take off, the numbers watching were impressive

https://www.facebook.com/199098633470668/posts/5275470005833480/

Not sure what the point is though

https://twitter.com/colhutch/status/1065640532750360576?s=19

Bosch release, electric bike partnership, u.n deal, Tetis, crop x, Kenya deal. The key to investing in small cap is to not be reliant on a single avenue. This is where I believe star comes into its own, each of the above could be company defining (for an mcap less than £10mln), there's much to be hopeful for. Good luck all

It never has been, nor do I expect it ever to be, dangerous. I do expect however, a cash call. Result, if you have an average higher than this, then it's going to be difficult to profit.

I don't expect any major investment into this either. During the trials I highlighted my concerns over patient distributions and how the numbers were not large enough to take anomalies. That's history now I guess.

When I say praying, what I mean is, some miracle deal to pull this out of the mire. It's shark infested waters, and imm would be negotiating from a position of weakness. For those that recall TM said when he raised £10mln, that having the cash strengthened his position in negotiating. We'll they're a long way from a position of strength imo

£9.02 - wages and expanses - £2mln TM have to the other company that he is CEO of for the cancer drug (strange transaction). Only got to last 2 years whilst the dosing of lupuzor continues with no income. The market knows it too!!!

No doubt you'll get the tampers praying and wishing for some miracle

I know what you mean, but I'm sure next week we will rerate, actually jokes aside, should get interims about then

You need to reread that particular section of the rns. It's not right that transaction, given TM job in both companies.

Nucant (cancer) programme: Clinical Development Collaboration with Incanthera Limited

Have a look at the Chairman of the company. Recognise him?

How much dilution over the two years, are they going to find any other of the pipeline? Cancer drug looks interesting? For me this has had its chance, TM was savvy raising £10mln, that should pay his salary for a while. Everyone is going to be diluted out of the game. You don't get the results you want, so they try and circumnavigate around it with "real world data"

Sorry don't see the FDA going for it. For lupuzor to work, I thought they had to conduct a trial one the subsection that appeared to respond. Sorry, think people are kidding themselves, single figure sp coming. Rainbow chasers and traders for a quick buck is all that's left. So much vs now, incredible

Don't like it, don't like this update one bit. Everyone saying great update, what is great about it? Put a load of buzz words in an rns and try and fool people into buying, to raise money. No mention of anything of any substance, what about the increased dosage that was discussed? Has this been recruited/carried out? Hardman have Val's cash position in the red, that's before we even get started on the warrants http://www.hardmanandco.com/research/companies/valirx-plc Anyway good luck

I don't know what it is, but aim companies seems to be vastly overvalued or under valued. I struggle as, brd are producing and with the extra production and better grade to come, this mcap looks bizarre. It's incorrect to say the court is done, but there's contingencies for every eventuality. We could conceivably do a couple 100k in revs in the next quarter, so to have a £2mln mcap is weird. Perhaps we're just ahead of the game, buy and hold for long term (substantial) rewards for me. Gla

Good news on mtfb today. The £3.6mln, assuming that was shares from amp. Was it enough to make all the loan repayments until the end of the year?

If it goes our way, it could be spectacular

For a company awaiting FS, then to arrange funding (which is a substantial length of time), then build the the plant, to the start production. It's still a long way away from production 18 months- 2yrs at best. Plus the drilling on beutong which all needs funding. The prospects look great and are relevant for the current climate, there seems to be a disconnect between the mcap imo. Factor the length of time before revenue and the dilution that must take place to get there. In truth most companies on aim are either over valued are under, I intend to buy but am biding my time for clarity

No, that's only if the company has been buying shares in the lead up to a buyout. As that is unlikely, they can offer whatever they feel is fair

I wonder if mms are forward selling amp shares, payment due for their creditors next month

https://www.businessdailyafrica.com/economy/Kenyan-vehicles-to-be-fitted-with-speed-tracking-gadgets/3946234-4689704-view-asAMP-hwvbw2/index.html?__twitter_impression=true Interesting

One of the big factors to why is hasn't risen is, three rns yesterday was "expected", so that invites traders, by in the run up, sell on the news. Investors or "believers" are not happy with ~20%, as we see the bigger picture. As quite rightly pointed out, the figures were an indication, also the accounting mishap at the start of the year. The next rns' at the end of August may be different though, the NDA lift materially changes the fundamentals and company exposure into new markets. It often rings true on small cap where the lack of liquidity means, not much price action has a big change. Good luck